Business

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia

Financial Post · September 1, 2026 at 6:04 p.m.

MONTREAL, Sept.

01, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has received regulatory approval from INVIMA, the Colombi

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia

More from Financial Post

Phoenix Tailings Advances Rare Earth Separation Engineering

Trident Provides Updated Information Regarding Its Marketing Engagement with Freedom Financial Research, LLC

This TSX stock could see nearly 32% upside after a huge India deal, analyst says

Brian Kesseler Named CEO of TekniPlex

More in Business

Phoenix Tailings Advances Rare Earth Separation Engineering

Trident Provides Updated Information Regarding Its Marketing Engagement with Freedom Financial Research, LLC

This TSX stock could see nearly 32% upside after a huge India deal, analyst says

Brian Kesseler Named CEO of TekniPlex

San Lorenzo Announces Upsize of Private Placement to Up to $80 Million

News of the day: Risky Nigerian mining, Super El Niño, banks in U.S. crosshairs, immigration boost, inheritance law and more